Bioactive Protein and Peptides Market By Type (Bioactive Proteins, Bioactive Peptides), By Source (Plant-Based, Animal-Based, Microbial, Synthetic), By Application (Pharmaceuticals, Nutraceuticals, Functional Foods, Cosmetics, Animal Nutrition), By End-Use (Healthcare Providers, Food & Beverage Industry, Pharmaceutical Companies, Biotech Companies), By Form (Powders, Liquids, Capsules/Tablets), and By Region; Global Insights & Forecast (2024 - 2030)

As per Intent Market Research, the Bioactive Protein and Peptides Market was valued at USD 8.1 billion in 2023 and will surpass USD 15.0 billion by 2030; growing at a CAGR of 9.2% during 2024 - 2030.

The bioactive proteins and peptides market has witnessed remarkable growth due to their vast applications across various industries such as pharmaceuticals, nutraceuticals, and cosmetics. These bioactive molecules play a vital role in promoting health benefits, enhancing metabolism, and improving immunity. The increasing awareness regarding the health benefits of bioactive compounds has led to higher adoption in dietary supplements and functional foods. Additionally, advancements in biotechnology and bioengineering are enabling the development of novel bioactive proteins and peptides, further expanding their market potential.

The market is also experiencing growth due to the rising demand for personalized nutrition, with bioactive proteins and peptides increasingly being used for targeted therapeutic treatments. These bioactive substances are derived from different sources like plants, animals, and microbes, offering varied health benefits depending on the origin. The growing prevalence of chronic diseases, coupled with the rising health-conscious consumer base, is anticipated to drive the demand for bioactive proteins and peptides in the coming years.

Bioactive Peptides Segment is Largest Owing to Increasing Demand for Functional Foods

The bioactive peptides segment dominates the bioactive protein and peptides market. Peptides, being smaller in size compared to proteins, are easier to absorb and provide targeted health benefits, making them increasingly popular in functional foods and dietary supplements. With the growing trend towards healthier lifestyles and personalized nutrition, bioactive peptides are being widely used to improve gut health, enhance immunity, and support muscle growth. Their incorporation into functional foods is particularly on the rise, as consumers demand more nutritionally dense products that offer specific health benefits beyond basic nutrition.

Bioactive peptides also find significant applications in the pharmaceutical industry, particularly in the development of peptide-based drugs. These drugs are gaining traction due to their effectiveness in treating various health conditions, including hypertension, cancer, and metabolic disorders. The increasing number of clinical trials focused on bioactive peptides and the growing body of scientific evidence supporting their health benefits are expected to further drive their growth in the market.

Animal-Based Source is Fastest Growing Due to Rising Demand for Natural Supplements

The animal-based source of bioactive proteins and peptides is the fastest-growing segment within the bioactive protein and peptides market. Animal-derived bioactive peptides, particularly from dairy, meat, and fish, are gaining traction due to their high nutritional value and superior bioavailability. The increasing preference for natural supplements among consumers is driving the growth of animal-based bioactive products. These peptides are known for their antioxidant, anti-inflammatory, and immune-boosting properties, making them highly desirable for health-conscious consumers looking for natural ways to support their wellness.

The growth of the animal-based segment is also fueled by advancements in animal protein extraction technologies, making it easier to isolate and purify specific bioactive peptides. The increasing consumption of animal-based protein products in both developed and developing regions, especially in the form of functional foods, further propels the demand for animal-based bioactive peptides.

Pharmaceuticals Application is Largest Owing to Increasing Focus on Health Solutions

The pharmaceuticals application segment holds the largest share in the bioactive protein and peptides market. Bioactive proteins and peptides are being increasingly utilized in the development of new drugs and therapeutic treatments for a wide range of diseases, including cardiovascular diseases, diabetes, and autoimmune disorders. The growing emphasis on precision medicine and the role of bioactive molecules in targeted drug delivery systems further supports the growth of this segment.

The pharmaceutical industry is also capitalizing on the natural properties of bioactive proteins and peptides, incorporating them into innovative drug formulations that promise fewer side effects compared to traditional chemical-based drugs. The rise of biotechnology companies focused on developing peptide-based therapies is expected to continue driving the growth of the pharmaceuticals segment.

Asia Pacific Region is Fastest Growing Owing to Rising Health Awareness

The Asia Pacific region is the fastest-growing market for bioactive proteins and peptides, driven by the increasing health awareness among consumers and the growing demand for functional foods and dietary supplements. The region’s large population base, along with the rising middle-class income, is contributing to a higher demand for nutritionally enriched products that promote wellness. Countries like China, India, and Japan are seeing significant growth in the adoption of bioactive proteins and peptides in various applications, from pharmaceuticals to functional foods.

Additionally, the rapid expansion of the pharmaceutical and biotechnology sectors in countries like India and China is fueling the demand for bioactive peptides in drug development. The increasing number of research initiatives and clinical trials focused on bioactive peptides in the region further supports its rapid growth, positioning Asia Pacific as a key player in the global bioactive proteins and peptides market.

Competitive Landscape and Leading Companies

The bioactive proteins and peptides market is highly competitive, with several key players involved in the development and commercialization of bioactive ingredients. Leading companies in this market include BASF SE, DuPont, DSM, and ADM. These companies are focusing on expanding their product portfolios and increasing their market presence through strategic acquisitions, partnerships, and collaborations. Additionally, several biotechnology startups are emerging, focusing on the development of novel bioactive peptides with specific health benefits.

The competitive landscape is characterized by significant investments in research and development activities aimed at discovering new bioactive peptides with therapeutic potential. As consumer demand for natural and functional products increases, companies are also looking to align their offerings with health-conscious trends, particularly those related to plant-based and animal-based bioactive peptides. The market is expected to remain dynamic, with companies continuing to innovate to meet evolving consumer preferences and regulatory standards.

Recent Developments:

• In November 2024, BASF SE launched a bioactive peptide for use in cardiovascular health supplements.
• In October 2024, Novozymes A/S developed a microbial-derived bioactive protein aimed at improving gut health.
• In September 2024, Glanbia plc introduced a functional protein blend targeting sports nutrition and recovery.
• In August 2024, Kerry Group plc expanded its portfolio with plant-based bioactive peptides for functional food applications.
• In July 2024, Koninklijke DSM N.V. announced a partnership to create bioactive protein solutions for use in therapeutic applications.

List of Leading Companies:

• BASF SE
• Koninklijke DSM N.V.
• Cargill, Incorporated
• Novozymes A/S
• Arla Foods Ingredients Group P/S
• Glanbia plc
• Kerry Group plc
• Nestlé Health Science
• Ingredion Incorporated
• Ajinomoto Co., Inc.
• Archer Daniels Midland Company
• Danisco A/S
• Bachem Holding AG
• Kemin Industries, Inc.
• Riken Vitamin Co., Ltd.

Report Scope: